Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish.
about
Role of serotonin in fish reproductionPharmaceuticals and personal care products in the environment: what are the big questions?Detection and drivers of exposure and effects of pharmaceuticals in higher vertebratesAdaptive capabilities and fitness consequences associated with pollution exposure in fishQuantitative structure-property relationships for predicting sorption of pharmaceuticals to sewage sludge during waste water treatment processesMedicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems.Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.Do hormone-modulating chemicals impact on reproduction and development of wild amphibians?An Assessment of the Spatial and Temporal Variability of Biological Responses to Municipal Wastewater Effluent in Rainbow Darter (Etheostoma caeruleum) Collected along an Urban Gradient.Pharmaceuticals and personal care products in waters: occurrence, toxicity, and risk.Development of a common carp (Cyprinus carpio) pregnane X receptor (cPXR) transactivation reporter assay and its activation by azole fungicides and pharmaceutical chemicals.Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autismAvian scavengers and the threat from veterinary pharmaceuticals.Computational estimation of rainbow trout estrogen receptor binding affinities for environmental estrogens.Kinetic determination of vitellogenin induction in the epidermis of cyprinid and perciform fishes: Evaluation of sensitive enzyme-linked immunosorbent assays.The effect of 17α-ethynylestradiol on steroidogenesis and gonadal cytokine gene expression is related to the reproductive stage in marine hermaphrodite fish.Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance.β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms.Green pharmacy and pharmEcovigilance: prescribing and the planet.Transcriptional changes in African clawed frogs (Xenopus laevis) exposed to 17α-ethynylestradiol during early development.A review of the effects of azole compounds in fish and their possible involvement in masculinization of wild fish populations.Returning to normal? Assessing transcriptome recovery over time in male rainbow darter (Etheostoma caeruleum) liver in response to wastewater-treatment plant upgrades.Widespread occurrence and potential for biodegradation of bioactive contaminants in Congaree National Park, USA.ACUTE EXPOSURE TO AN ENVIRONMENTALLY-RELEVANT CONCENTRATION OF DICLOFENAC ELICITS OXIDATIVE STRESS IN THE CULTURALLY IMPORTANT GALAXIID FISH, GALAXIAS MACULATUS.Investigating Research Gaps of Pharmaceutical take back Events: An Analysis of take back Program Participants' Socioeconomic, Demographic, and Geographic Characteristics and the Public Health Benefits of take back Programs.Derivation and Evaluation of Putative Adverse Outcome Pathways for the Effects of Cyclooxygenase Inhibitors on Reproductive Processes in Female Fish.Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country.Individual and mixture toxicity of pharmaceuticals naproxen, carbamazepine, and sulfamethoxazole to Australian striped marsh frog tadpoles (Limnodynastes peronii).Flexing the PECs: Predicting environmental concentrations of veterinary drugs in Canadian agricultural soils.Simvastatin effects on detoxification mechanisms in Danio rerio embryos.Introduction of human pharmaceuticals from wastewater treatment plants into the aquatic environment: a rural perspective.Rapid analysis of diclofenac in freshwater and wastewater by a monoclonal antibody-based highly sensitive ELISA.Occurrence of 25 pharmaceuticals in Taihu Lake and their removal from two urban drinking water treatment plants and a constructed wetland.An ecological perspective on medical care: environmental, occupational, and public health impacts of medical supply and pharmaceutical chains.In vivo and in vitro liver and gill EROD activity in rainbow trout (Oncorhynchus mykiss) exposed to the beta-blocker propranolol.A comparison of the environmental impact of different AOPs: risk indexes.Ozonation of metoprolol in aqueous solution: ozonation by-products and mechanisms of degradation.Prozac in the water: Chronic fluoxetine exposure and predation risk interact to shape behaviors in an estuarine crab.Chronic diclofenac (DCF) exposure alters both enzymatic and haematological profile of African catfish, Clarias gariepinus.
P2860
Q26829080-5B4A591E-4019-414C-B252-4314E2A10104Q26859139-75C665A6-3E6E-4AD1-89D1-80AF8E1205A8Q26859188-96A48ED8-F3D8-4B30-82AE-6F03475DFF50Q28078890-3F66362A-68E2-43FD-B3F0-2B5E0CBEC84BQ28818253-0C83B464-D621-4633-90DB-37284BD8E28DQ30390250-66006D57-076F-4DFD-A655-05D8406DA53FQ30459493-63A51F10-C25D-41F0-8A47-698636CB264CQ30863579-6FA17462-EB43-4791-A5A8-F565E17A9FE8Q31138731-5364BB57-9841-40F3-87B2-BF02A05B5214Q33764240-155EFA12-1319-4234-BF8F-062F01E3670AQ33835410-E5727898-5675-488F-B7C5-95C2C6AE61DBQ34296925-0B64D333-2E93-44CD-AD27-2C994178FF42Q34305076-0B7FCEFC-A6C7-466A-BEE5-4A871C3B2872Q34423515-BD74CAD9-3615-482F-BD36-8AED428522BAQ34496623-053C3DBA-7FD9-40EA-999E-F2D35216FDBEQ36011019-3D7774C3-6625-4515-AFD6-ABC1FCEC15B5Q37424980-A2E44A01-3792-4000-8E3D-C4BEC6B25FCBQ37552507-DC39F1BB-96D4-4D91-9C0B-C04C20978340Q37849264-5141FD06-7E13-4627-B998-4FEFD15C5266Q37960637-C25481A3-8AB0-4740-AC90-1193339FE792Q38415462-3555019A-3647-4A54-BA8B-5ED4F0E108D0Q38433480-E15477C5-9679-4BDA-9F2B-C20315656AACQ38437915-394668FE-2870-4467-9388-A5B7E1CDAE82Q38557360-A74D5E4F-19AC-4FE4-9A8A-DA6997E03EECQ38627933-766B1E68-8AE6-49FB-A498-9F5F0431D595Q38750912-94D46792-2EDF-4D5B-B5E4-53B69093ED80Q38959910-C5FF5B48-319A-4CAA-B584-D71F0CD790DFQ38979288-06E6CEA2-D899-45EE-86D9-C119950CD516Q39239569-4FA031E7-F6EB-4AC4-96AB-7FF31DE70E16Q39554611-0A405906-32D6-4D80-A0F7-6EEA409697F9Q39867414-19869554-3D40-4767-A37C-4498324DDADAQ40261065-1A399C11-30EA-424B-9631-A66C06BB5B54Q40463555-1FCA112E-2A5A-4158-9957-C118BBC5B5A0Q40467200-F140D263-4BB3-482F-9702-D3D74D17B1CBQ42255628-71532398-13D6-44D7-93BF-1EDFD2B0B2EAQ42746972-8EAEA2A1-7F12-4D50-8FC4-00005E2AC3D6Q43327864-B9404E18-A411-4B9C-8B1D-87A7498A7A09Q43350455-B2B78AC7-8FE5-47B1-B9B3-8EAB0712AA2BQ45336791-5C618FA4-541A-4BB1-8EB9-3C87ADD12E2CQ46457203-BB37A5F2-A2E3-49C0-9546-019A1A65813E
P2860
Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmaceuticals in the aquatic ...... ce for health effects in fish.
@en
Pharmaceuticals in the aquatic ...... ce for health effects in fish.
@nl
type
label
Pharmaceuticals in the aquatic ...... ce for health effects in fish.
@en
Pharmaceuticals in the aquatic ...... ce for health effects in fish.
@nl
prefLabel
Pharmaceuticals in the aquatic ...... ce for health effects in fish.
@en
Pharmaceuticals in the aquatic ...... ce for health effects in fish.
@nl
P2093
P2860
P1476
Pharmaceuticals in the aquatic ...... ce for health effects in fish.
@en
P2093
Charles R Tyler
Jenna Corcoran
Matthew J Winter
P2860
P304
P356
10.3109/10408440903373590
P407
P577
2010-04-01T00:00:00Z